Keep making progress with regular check-ins, expert guidance, and access to your care team 24/7
A randomized controlled trial conducted on obese people has shown that a 12-week treatment with Liraglutide can reduce binge eating behavior and cause weigh loss in patients with binge eating disorder
side effects, kidney issues, gallstone issues," Dr
It was developed in the 1990s, gained FDA approval in 2005 for type 1 and insulin-treated type 2 diabetes research and clinical use, and demonstrated that amylin signaling could be safely engaged in clinical research populations
Semaglutide has shown superior weight loss efficacy in general obesity populations (with average weight loss of 1015% of body weight in major trials)
Both are typically administered via intramuscular or subcutaneous injection, and they do not compete for the same metabolic pathways or receptors